Guidance

Merger rules: how they affect pathology service reconfigurations

Guidance for NHS providers and commissioners on the application of merger control rules to pathology service reconfigurations.

From:
Monitor
Published
3 June 2013

Applies to England

Documents

Briefing note on the application of merger control rules to pathology service reconfigurations

PDF, 706 KB, 7 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document outlines how rules on mergers can affect changes to pathology services in the NHS.

It also details the roles of Monitor and the Office of Fair Trading in a merger review.

For further information about the content of this note, or any related issue, please contact cooperationandcompetition@monitor.gov.uk.

Questions for the OFT in relation to mergers should be addressed to healthcare.mergers@oft.gsi.gov.uk.

Published 3 June 2013

Related content